Pregabalin
Form: Oral Solution
Strength: 20 mg/mL
Reference Brands: Lyrica(US & EU)
Category: Antipsychotropic Drugs
Pregabalin is an antiepileptic and neuropathic pain agent approved for conditions like fibromyalgia, diabetic neuropathy, postherpetic neuralgia, and generalized anxiety disorder. It is commercially available in oral capsule (25–300 mg), oral solution (20 mg/mL), and extended-release tablet (82.5–330 mg) formats. Marketed under the brand Lyrica by Pfizer in the US and EU, it is also widely available as a generic. Pregabalin is a high-demand CNS product due to its therapeutic versatility. Pharma B2B suppliers targeting neurology, pain management, and psychiatric markets find Pregabalin a key listing for regulated pharmaceutical export and commercial distribution in the US and European regions.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details
Zuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details
Zuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details